and be a part of a multi-disciplinary preclinical research team. You will manage Client projects in the field of drug discovery... from charity occasions to fun team events. More info: Associate Director Laboratory Sciences, Tuulia Huhtala (+358504366373...
! As we are adapting new therapies, we are in search for new team members to join us. We are looking for ResearchAssociate (RA) to support... and skills to be a key collaborator between our scientific and technical teams in preclinical research. In this position...
! We are expanding our operations and therefore, we are now looking for a Research Leader to strengthen our drug development services. In... recreational committee which organizes activities from charity occasions to fun team events. More info: Associate Director...
/immunohistochemistry procedures, in vitro- work or other bioanalytical assays in preclinical research. The position is permanent and full.... We also offer you e.g., broad occupational healthcare, leisure accident insurance and ePassi flex- benefit. More info: Associate Director...
The BBC hears the owner of the luxury store scoped out his victims on the shop floor, assaulted them in London, Paris and St Tropez, and pressured them to keep quiet. Continue Reading »
Sebi initiated action into Axis Capital after publication of a report titled ‘Is Axis Capital an Investment Bank or a Hedge Fund?’ authored by a research analyst. Continue Reading »
Experts rule out a runaway rally, given the steep valuations across large swathes of the market, expecting large caps to outperform broader markets. Continue Reading »
As of 10 a.m. Eastern time, the Dow Jones was up 1.2 per cent, the Nasdaq Composite was 2.2 per cent higher, and the S&P 500 was 1.5 per cent higher Continue Reading »
While foreign investors remain wary due to high valuations, Wood believes India’s domestic fundamentals will help cushion its markets from global volatility. Continue Reading »
The Indian stock market has gained significantly this year, with the Sensex up 15% and Nifty 50 up 17%. Experts recommend quality stocks for long-term gains amid optimism and caution. Top picks include Persistent Systems and HDFC Life. Continue Reading »
Earlier this month, global brokerage firm Goldman Sachs downgraded Indus Towers from a 'Neutral' rating to 'Sell,' lowering the target price to ₹220. Continue Reading »
Centrum Broking has initiated coverage on the wealth management sector, issuing a REDUCE rating for 360 One WAM and Nuvama Wealth. Target prices are ₹1,050 and ₹7,180, respectively, reflecting downsides for both amid a growing market for wealth management in India. Continue Reading »